Literature DB >> 18945396

Are psychological and pharmacologic interventions equally effective in the treatment of adult depressive disorders? A meta-analysis of comparative studies.

Pim Cuijpers1, Annemieke van Straten, Patricia van Oppen, Gerhard Andersson.   

Abstract

OBJECTIVE: A large number of studies suggest that both psychological and pharmacologic therapies are effective in the treatment of mild-to-moderate depressive disorders. Whether both types of intervention are equally effective has not been established definitively. DATA SOURCES: A database was developed through a comprehensive literature search (from 1966 to May 2007) in which 6947 abstracts in PubMed (1244 abstracts), PsycINFO (1736), EMBASE (1911), and the Cochrane Central Register of Controlled Trials (2056) were examined. Abstracts were identified by combining terms indicative of psychological treatment and depression (both MeSH terms and text words). For this database, the primary studies from 22 meta-analyses of psychological treatment for depression were also collected. STUDY SELECTION: For the current study, the abstracts of 832 studies were examined. DATA EXTRACTION: Thirty randomized trials were included in a meta-analysis that compared the effects of a psychological treatment for 3178 adults with a diagnosed depressive disorder (major depressive disorder, dysthymia, minor depressive disorder) with the effects of a pharmacologic treatment. DATA SYNTHESIS: In studies of patients with dysthymia, pharmacotherapy was significantly more effective than psychotherapy (d = -0.28, 95% CI = -0.47 to -0.10). In patients with major depressive disorder, treatments with selective serotonin reuptake inhibitors (SSRIs) were significantly more effective than psychological treatments, while treatment with other antidepressants did not differ significantly. Subgroup and metaregression analyses did not show that pretest severity of depressive symptoms was associated with differential effects of psychological and pharmacologic treatments of major depressive disorder. Dropout rates were smaller in psychological interventions compared with pharmacologic treatments (odds ratio = 0.66, 95% CI = 0.47 to 0.92).
CONCLUSIONS: Pharmacologic treatments may be more effective than psychological interventions in the treatment of dysthymia. Pharmacologic treatment with SSRIs may also be more effective in the treatment of major depressive disorder, although these differences are small and probably have little meaning from a clinical point of view. We can conclude that both psychological and pharmacologic therapies are effective in the treatment of depressive disorders and that each has its own merits. Copyright 2008 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18945396     DOI: 10.4088/jcp.v69n1102

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  51 in total

1.  The efficacy and acceptability of psychological interventions for depression: where we are now and where we are going.

Authors:  Steven D Hollon
Journal:  Epidemiol Psychiatr Sci       Date:  2015-08-27       Impact factor: 6.892

2.  The severity of psychiatric disorders.

Authors:  Mark Zimmerman; Theresa A Morgan; Kasey Stanton
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

3.  Implementation of universal behavioral health screening in a university health setting.

Authors:  Robyn L Shepardson; Jennifer S Funderburk
Journal:  J Clin Psychol Med Settings       Date:  2014-09

4.  The promise of cognitive behavior therapy for treatment of severe mental disorders: a review of recent developments.

Authors:  Michael E Thase; David Kingdon; Douglas Turkington
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

Review 5.  Economic evidence for the clinical management of major depressive disorder: a systematic review and quality appraisal of economic evaluations alongside randomised controlled trials.

Authors:  E Karyotaki; D Tordrup; C Buntrock; R Bertollini; P Cuijpers
Journal:  Epidemiol Psychiatr Sci       Date:  2016-06-22       Impact factor: 6.892

6.  General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.

Authors:  Thomas C Baghai; Pierre Blier; David S Baldwin; Michael Bauer; Guy M Goodwin; Kostas N Fountoulakis; Siegfried Kasper; Brian E Leonard; Ulrik F Malt; Dan Stein; Marcio Versiani; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11       Impact factor: 5.270

Review 7.  Listening Visits for maternal depression: a meta-analysis.

Authors:  Jennifer E McCabe; Birgitta Wickberg; Jennifer Deberg; Rebecca Chuffo Davila; Lisa S Segre
Journal:  Arch Womens Ment Health       Date:  2021-01-15       Impact factor: 3.633

Review 8.  Major depressive disorder: new clinical, neurobiological, and treatment perspectives.

Authors:  David J Kupfer; Ellen Frank; Mary L Phillips
Journal:  Lancet       Date:  2011-12-19       Impact factor: 79.321

Review 9.  Interpersonal psychotherapy for depression: a meta-analysis.

Authors:  Pim Cuijpers; Anna S Geraedts; Patricia van Oppen; Gerhard Andersson; John C Markowitz; Annemieke van Straten
Journal:  Am J Psychiatry       Date:  2011-03-01       Impact factor: 18.112

10.  Stepped care for depression and anxiety: from primary care to specialized mental health care: a randomised controlled trial testing the effectiveness of a stepped care program among primary care patients with mood or anxiety disorders.

Authors:  Wike Seekles; Annemieke van Straten; Aartjan Beekman; Harm van Marwijk; Pim Cuijpers
Journal:  BMC Health Serv Res       Date:  2009-06-05       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.